Hybridon
Hybridon, Inc was a biotechnology company based in Cambridge, Massachusetts, specializing in the discovery and development of novel therapeutics and diagnostics using synthetic DNA, that merged with Idera Pharmaceuticals in 2004.Notable investors
According to a US Securities and Exchange Commission filing of May 4, 1999 Hybridon had investors with 5% or more ownership including:
